Authors
Reona Kawamura, Masayoshi Yamada, Hiroyuki Takamaru, Takeshi Nakajima, Seiichiro Abe, Satoru Nonaka, Ichiro Oda, Noriko Tanabe, Makoto Hirata, Yutaka Saito
Published in
DEN open. Volume 7. Issue 1. Pages e70419. Epub Sep 11, 2026.
Abstract
Familial adenomatous polyposis (FAP) is a genetic condition that increases the risk of developing colorectal polyposis and cancer, as well as superficial non-ampullary duodenal epithelial tumors (SNADETs). In this single-center retrospective study, we investigated the long-term clinical outcomes of intensive endoscopic resection for downstaging the SNADET burden (intensive downstaging polypectomies [IDPs]) in individuals with FAP.
Of 56 patients with FAP who underwent endoscopic treatment of SNADETs, 34 underwent IDPs, and 22 underwent conventional treatments, with a median follow-up period of 71 months. IDP was defined as the resection of ≥ 3 lesions in one treatment.
The total number of resected lesions was 495 lesions (9.7 ± 7.5 lesions/treatment [average ± standard deviation]) in the IDP group and 42 (1.4 ± 0.5 lesions/treatment) in the conventional group. No delayed bleeding was observed in the IDP group and one in the conventional group. No perforation was observed in our study. The 5-year incidence rates of high-grade dysplasia, invasive cancer, and cause-specific duodenectomy in the IDP group were 15.6%, 3.6%, and 0%, respectively. Downstaging of the Spigelman stage (SS) was achieved in 50% (17/34) of patients in the IDP group.
This study demonstrated that IDP was safe and effective in downstaging the burden of SNADETs, and no duodenectomy due to SNADETs was required during the available follow-up period in individuals with FAP, even at SS IV.
N/A.
PMID:
42732135
Bibliographic data and abstract were imported from PubMed on 13 Sep 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 6
- Comments 0